Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 4 Prostatic Neoplasms 2 Neoplasm Metastasis 2 With MSS/pMMR Advanced, Platinum-resistant Ovarian Cancer 1 Smoldering Multiple Myeloma 1 Osteoporosis 1 Multiple Myeloma 1 Melanoma 1 Mastocytosis, Systemic 1 Giant Cell Tumor of Bone 1 Clear-cell metastatic renal cell carcinoma 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1

Interventions

avapritinib 4 dexamethasone acetate 1 dexamethasone 21-phosphate 1 auricularum 1 Thalidomide 1 Ranitidine 1 Ibuprofen 1 Diphenhydramine 1 Dexamethasone 1 Denosumab 1 Calcium Dobesilate 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Mastocytosis, Systemic × Denosumab × 1 year × Clear all

NCT03401060 2026-03-31

DenosuMast

Assistance Publique - Hôpitaux de Paris

Phase 3 Completed

Osteoporosis, Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡